Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ceska Slov Farm ; 72(4): 172-183, 2023.
Article in English | MEDLINE | ID: mdl-37805263

ABSTRACT

Neuroinflammation plays an important role in the pathogenesis of epilepsy, so it is necessary to clarify the influence of standard antiepileptic drugs as well as adjuvant agents (e.g., cardiac glycoside digoxin, which previously showed a clear anticonvulsant potential) on cyclooxygenase pathway and neuron-specific enolase under the conditions of chronic epileptogenesis. The aim of the article is to determine the effect of digoxin, sodium valproate, and celecoxib per se, as well as the combination of digoxin with sodium valproate on the content of cyclooxygenase 1 and 2 types, prostaglandins E2, F2α, I2, thromboxane B2, 8-isoprostane and neuron-specific enolase in the brain of mice in the pentylenetetrazole-induced kindling model. It was found that only the combination of sodium valproate with digoxin provides a complete protective effect (absence of seizures) and shows the clearest influence on neuroinflammation markers and neuronal damage than monotherapy with each of these drugs and celecoxib, which appeared to be an ineffective anticonvulsant. The obtained results indicate that digoxin is a promising adjuvant drug to classical antiepileptic drugs (mostly sodium valproate) in epilepsy treatment.c.


Subject(s)
Epilepsy , Valproic Acid , Rats , Mice , Animals , Valproic Acid/pharmacology , Valproic Acid/therapeutic use , Anticonvulsants/pharmacology , Anticonvulsants/therapeutic use , Pentylenetetrazole/pharmacology , Pentylenetetrazole/therapeutic use , Celecoxib/pharmacology , Celecoxib/therapeutic use , Prostaglandin-Endoperoxide Synthases/therapeutic use , Digoxin/therapeutic use , Neuroinflammatory Diseases , Rats, Wistar , Epilepsy/chemically induced , Epilepsy/drug therapy , Phosphopyruvate Hydratase/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...